Patent application number | Description | Published |
20090266824 | CAN END - A beverage can end is described. The beverage can end has a curl defining a perimeter of the can end, a chuckwall extending downwardly and radially inwardly from the curl, and a transition wall joining the chuckwall to an outer peripheral edge of a center panel. The transition wall is formed in compression such that a portion of the transition wall exhibits a compressed segment having a thickness which is 1% to 20% thicker than a thickness of the center panel. | 10-29-2009 |
20090269169 | CAN END - In a method of forming a beverage can end wherein a beverage can end shell has a curl defining a perimeter of the can end, a chuckwall extending downwardly and radially inwardly from the curl, a generally U-shaped countersink joining the chuckwall to an outer peripheral edge of a center panel, a method of forming an arcuate chuckwall in the beverage can end shell is described. The method of forming the arcuate chuckwall comprises the steps of providing a partially formed can end, providing an upper tooling having an annular, generally arcuate segment, and providing a lower tooling having a circumferential, generally arcuate, outwardly convex segment in at least partial alignment with the annular, generally arcuate segment of the upper tooling. The annular, generally arcuate segment of the upper tooling and the circumferential, generally arcuate, outwardly convex segment of the lower tooling are brought into engagement with a public side and a product side of the partially formed can end, respectively. A portion of the partially formed can end is reformed to form a circumferential, generally arcuate, outwardly convex segment located between an upper bend in the can end having a center of curvature above a public side of the can end and a lower bend in the partially formed can end having a center of curvature below the public side of the partially formed can end. | 10-29-2009 |
20130167607 | SYSTEM AND METHOD FOR FORMING A METAL BEVERAGE CONTAINER USING PRESSURE MOLDING - A system and method of manufacturing a metal vessel may include inserting a preform into a mold that includes multiple segments, the preform being a work hardened metal. A pre-pressure may be applied to the preform at a first pressure level. The multiple segments of the mold may be closed, and the pressure being applied to the preform may be increased using a step function to a second pressure level after the mold is closed to cause the preform to take a shape defined by the mold. | 07-04-2013 |
20130192053 | SYSTEM AND METHOD FOR FORMING A METAL BEVERAGE CONTAINER USING BLOW MOLDING - A system and method of manufacturing a metal vessel may include providing a preform formed of a work hardened metal that includes an open portion, a closed end portion, and body portion. The body portion of the preform may be preheated in a manner that limits heat being applied to the open portion and closed end portion of the preform. The preheated preform may be blow molded. | 08-01-2013 |
20130220964 | METAL BEVERAGE CONTAINER WITH IMPROVED FINISH GEOMETRY - A metal beverage container may include a body portion, a neck portion connected with said body portion, and a finish portion. The finish portion may include a threaded portion, a lip portion, and a transition portion coupled between the threaded portion and the lip portion. The transition portion may include an outwardly convex shape. | 08-29-2013 |
20130259608 | METHOD OF FORMING A VESSEL - A system and method of forming a vessel may include providing multiple operation wheels configured in opposing facing pairs. Each operation wheel may include multiple work zones, each work zone of an operation wheel being configured in an opposing facing pair with a work zone of another operation wheel to engage the vessel and perform a forming operation on the vessel. Opposing facing pairs of the operation wheels may be linearly pushed to a closed position to engage the vessel, and pulled to an open position. The work zone(s) may perform least one forming operation on the vessel. The vessel may be indexed through the operations at a rotational timing coordinated to index the vessel when opposing facing pairs of the operation wheels are in the open position, the indexing may be clockwise or counterclockwise based on whether a decoration operation is to be performed on the vessel. | 10-03-2013 |
20150074982 | SYSTEM AND METHOD FOR FORMING A METAL BEVERAGE CONTAINER USING BLOW MOLDING - A system and method of manufacturing a metal vessel may include providing a preform being formed of a work hardened metal. The preform may have an open portion, a closed end portion, and body portion. A multiple segment mold may be closed around the preform. The preform may be blow molded by causing a step-like change in pressure within the preform to cause the preform to take a shape defined by the mold. The molded preform may be removed from the mold. | 03-19-2015 |
Patent application number | Description | Published |
20090247536 | Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use - Embodiments of the present invention provide bissulfonamide compounds that are agonists of GalR1. The present invention further provides compositions comprising bissulfonamide compounds that are agonists of GalR1, and methods of use of such compounds and compositions. | 10-01-2009 |
20100152170 | Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors - The present invention relates to compounds and methods from the treatment of cancer. The invention provides compounds that inhibit Aurora kinase, pharmaceutical compositions comprising compounds that inhibit Aurora kinase, and methods for the treatment of cancer using the compounds of the presentation invention or pharmaceutical compositions comprising compounds of the present invention. | 06-17-2010 |
20120088778 | AZOLE DERIVATIVES AND FUSED BICYCLIC AZOLE DERIVATIVES AS THERAPEUTIC AGENTS - This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, β-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. | 04-12-2012 |
Patent application number | Description | Published |
20120264702 | Synthesis And Use Of Glycoside Derivatives of Propofol - The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug propofol analogs. This invention relates to a method for the production of a broad group of glycosylated propofol carbohydrate derivatives. | 10-18-2012 |
20120295866 | Synthesis And Use Of Glycoside Pro-Drug Analogs - The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs. This invention relates to a method for the production of a broad group of glycosylated drugs, including but not limited to propofol, acetaminophen, and camptothecin carbohydrate derivatives. | 11-22-2012 |
20130217640 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG - The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of acetaminophen derivatives. | 08-22-2013 |
Patent application number | Description | Published |
20100286197 | Carboxamide Derivatives As Therapeutic Agents - This invention provides certain compounds, methods of their preparation, pharmaceutical compositions comprising the compounds, and their use in treating human or animal disorders. The compounds of the invention are useful as modulators of the interaction between the receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, β-amyloid and amphoterin, and for the management, treatment, control, or as an adjunct treatment for diseases in humans caused by RAGE. Such diseases or disease states include acute and chronic inflammation, the development of diabetic late complications such as increased vascular permeability, nephropathy, atherosclerosis, and retinopathy, the development of Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. | 11-11-2010 |